Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2020 May 20;11:188. doi: 10.1186/s13287-020-01686-8

Correction to: miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells

Chen-Fei Zhou 1, Min-Juan Liu 2, Wei Wang 1, Sha Wu 3, Yu-Xin Huang 2, Guo-Bin Chen 4, Li-Min Liu 4, Dong-Xian Peng 2, Xue-Feng Wang 2, Xu-Zi Cai 2, Xiao-Xuan Li 2, Wan-Qin Feng 2, Ying Ma 2,
PMCID: PMC7238729  PMID: 32434593

Correction to: Stem Cell Res Ther (2019) 10:287

https://doi.org/10.1186/s13287-019-1388-5

The original article [1] contains an error in Fig. 1 whereby in sub-panel A of Fig. 1, the blue and red thresholds were mistakenly reversed. The correct version of sub-panel A in Fig. 1 can be viewed ahead.

Fig. 1.

Fig. 1

Identification of miR-205-5p as a negatively pathologic miRNA in endometriosis. a The different miRNA expression profiles between the EN (n = 3) and EC (n = 3) groups were analysed by miRNA microarray. The heatmap diagram shows that the representative miRNAs were significantly associated with endometriosis. EN1, EN2, and EN3 indicate 3 normal endometria; EC1, EC2, and EC3 indicate 3 ectopic endometria. b The levels of 16 differentially expressed miRNAs in the endometrium used for microarray analysis were analysed by qRT-PCR. c, d The levels of miR-205-5p, miR-4497, miR-3154, and miR-3926 were validated by qRT-PCR in additional tissues and serum from the EN (n = 23) and EC (n = 68) groups. EN, normal endometrium; EC, ectopic endometrium. Error bars represent the mean ± SD of 3 independent experiments. n.s., not significant; *P < 0.05; **P < 0.01; ***P < 0.001

Reference

  • 1.Zhou C-F, et al. miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells. Stem Cell Res Ther. 2019;10:287. doi: 10.1186/s13287-019-1388-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES